The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met June 21–23, 2023, to discuss respiratory syncytial virus (RSV) vaccines, influenza vaccines, pneumococcal vaccines, meningococcal vaccines, and COVID-19 vaccines. The ACIP also held a special meeting on August 3, 2023, to discuss RSV prophylaxis in infants. This update summarizes the proceedings of these meetings that are most relevant to the pediatric population. Major updates for pediatric clinicians include a new recommendation for the monoclonal antibody nirsevimab for prevention of RSV disease in all infants, recommendations regarding use of 20-valent pneumococcal conjugate vaccine, and discussion of potential forthcoming changes to meningococcal and COVID-19 vaccination recommendations.
Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines
Sean T. O’Leary, Alexandra B. Yonts, Claudia Gaviria-Agudelo, David W. Kimberlin, Grant C. Paulsen; Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines. Pediatrics November 2023; 152 (5): e2023063955. 10.1542/peds.2023-063955
Download citation file: